Loading...
Teleflex Incorporated
TFX•NYSE
Healthcare
Medical - Instruments & Supplies
$115.56
$-1.63(-1.39%)
Teleflex Incorporated (TFX) Financial Performance & Income Statement Overview
Review Teleflex Incorporated’s income statement, balance sheet, and cash flow reports with annual and quarterly breakdowns.
Revenue Growth
2.45%
↑ 2.45%
Operating Income Growth
-70.17%
↓ 70.17%
Net Income Growth
-80.45%
↓ 80.45%
Operating Cash Flow Growth
24.50%
↑ 24.50%
Operating Margin
9.66%
↑ 9.66%
Gross Margin
55.72%
↑ 55.72%
Net Profit Margin
4.96%
↑ 4.96%
ROE
3.43%
↑ 3.43%
ROIC
4.48%
↑ 4.48%
Teleflex Incorporated (TFX) Income Statement & Financial Overview
Review Teleflex Incorporated's (TFX) income statement with detailed quarterly and annual figures.
| Metric | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 |
|---|---|---|---|---|
| Revenue | $795.41M | $764.38M | $749.69M | $737.85M |
| Cost of Revenue | $355.49M | $334.20M | $331.83M | $321.71M |
| Gross Profit | $439.92M | $430.17M | $417.86M | $416.13M |
| Gross Profit Ratio | $0.55 | $0.56 | $0.56 | $0.56 |
| R&D Expenses | $44.55M | $38.73M | $41.09M | $37.30M |
| SG&A Expenses | $254.55M | $247.26M | $250.63M | $242.83M |
| Operating Expenses | $559.50M | $285.98M | $291.73M | $280.13M |
| Total Costs & Expenses | $905.79M | $620.19M | $623.56M | $601.84M |
| Interest Income | $2.26M | $2.30M | $1.79M | $1.67M |
| Interest Expense | $18.64M | $21.06M | $21.17M | $22.68M |
| Depreciation & Amortization | $71.79M | $68.64M | $68.13M | $66.04M |
| EBITDA | -$32.03M | $224.87M | $191.42M | $62.92M |
| EBITDA Ratio | -$0.04 | $0.29 | $0.26 | $0.09 |
| Operating Income | -$110.38M | $149.31M | $126.13M | $136.005M |
| Operating Income Ratio | -$0.14 | $0.20 | $0.17 | $0.18 |
| Other Income/Expenses (Net) | -$16.38M | -$18.76M | -$28.64M | -$21.02M |
| Income Before Tax | -$126.76M | $130.55M | $97.50M | -$25.81M |
| Income Before Tax Ratio | -$0.16 | $0.17 | $0.13 | -$0.03 |
| Income Tax Expense | $9.90M | $19.63M | $17.33M | -$41.55M |
| Net Income | -$136.66M | $111.004M | $80.04M | $15.29M |
| Net Income Ratio | -$0.17 | $0.15 | $0.11 | $0.02 |
| EPS | -$2.95 | $2.38 | $1.70 | $0.32 |
| Diluted EPS | -$2.95 | $2.36 | $1.69 | $0.32 |
| Weighted Avg Shares Outstanding | $46.32M | $46.72M | $47.15M | $47.07M |
| Weighted Avg Shares Outstanding (Diluted) | $46.37M | $47.01M | $47.36M | $47.39M |
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan